VVOSVivos Therapeutics, Inc.

Nasdaq vivos.com


$ 2.19 $ -0.30 (-12.05 %)    

Wednesday, 15-May-2024 10:46:50 EDT
QQQ $ 452.60 $ 3.65 (0.81 %)
DIA $ 398.41 $ 0.53 (0.13 %)
SPY $ 528.84 $ 2.92 (0.56 %)
TLT $ 92.06 $ 0.22 (0.24 %)
GLD $ 220.86 $ 1.62 (0.74 %)
$ 2.49
$ 2.13
$ 0.00 x 0
$ 0.00 x 0
$ 2.11 - $ 2.19
$ 1.96 - $ 48.79
312,434
na
5.75M
$ 4.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 08-16-2023 06-30-2023 10-Q
4 06-08-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 12-20-2022 09-30-2022 10-Q
7 12-20-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vivos-therapeutics-q1-eps-163-up-from-172-yoy-sales-342m-down-from-386m-yoy

Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(1.63) per share. This is a 5.23 percent increase over losses of...

 whats-going-on-with-vivos-therapeutics-stock

Vivos Therapeutics shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million...

Core News & Articles
Market-Moving News for April 9th
04/09/2024 12:56:00

LASE: 167% | Laser Photonics shares are trading higher after the company announced it secured an order for its LaserTower COMPA...

 vivos-therapeutics-flagship-care-oral-medical-devices-receive-full-approval-for-medicare-reimbursement

 Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ:VVOS), a leading medical device and technology company specializin...

 vivos-therapeutics-has-received-a-notice-of-allowance-for-its-us-patent-application-17522740-titled-vibrational-oral-appliance-with-mandibular-advancements-to-provide-relief-from-sleep-disordered-breathing-sleep-apnea-andor-snoring

https://patentcenter.uspto.gov/applications/17522740/ifw/docs 

 why-doma-holdings-shares-are-trading-higher-by-around-34-here-are-20-stocks-moving-premarket

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transa...

 vivos-therapeutics-q4-2023-gaap-eps-305-misses-191-estimate-sales-3248m-miss-3406m-estimate

Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(3.05) per share which missed the analyst consensus estimate of ...

 vivos-therapeutics-announces-exercise-of-warrants-for-4m-aggregate-gross-proceeds

Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology comp...

 why-u-power-shares-are-trading-lower-by-around-54-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of reg...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION